83 FR 22504 - National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 94 (May 15, 2018)

Page Range		22504-22505
FR Document		2018-10237

Federal Register, Volume 83 Issue 94 (Tuesday, May 15, 2018)

[Federal Register Volume 83, Number 94 (Tuesday, May 15, 2018)]
[Notices]
[Pages 22504-22505]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-10237]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.The meetings 
will be closed to the public in accordance with the provisions set 
forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as 
amended. The grant applications and the discussions could disclose 
confidential trade secrets or commercial property such as patentable 
material, and personal information concerning individuals associated 
with the grant applications, the disclosure of which would constitute a 
clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; DDK-B Conflicts.
    Date: June 6-7, 2018.
    Time: 8:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Garden Inn Bethesda, 7301 Waverly Street, 
Bethesda, MD 20814.
    Contact Person: Thomas A. Tatham, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7021, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 
594-3993, tathamt@mail.nih.gov.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; NIDDK Clinical Trials.
    Date: June 19, 2018.
    Time: 1:30 p.m. to 3:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Elena Sanovich, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7351, 6707 Democracy Boulevard, Bethesda, MD 20892-2542, 301-
594-8886, sanoviche@mail.nih.gov.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; NIDDK Program Projects.
    Date: June 21, 2018.
    Time: 11:30 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Elena Sanovich, Ph.D., Scientific Review 
Officer, Review Branch, DEA, IDDK, National Institutes of Health, 
Room 7351, 6707 Democracy Boulevard, Bethesda, MD 20892-2542, 301-
594-8886, sanoviche@mail.nih.gov.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; PAR-18-108: NIDDK 
Exploratory Clinical Trials for Small Business (R44 Clinical Trial 
Required).
    Date: June 21, 2018.
    Time: 12:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Najma S. Begum, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7349, 6707 Democracy Boulevard,

[[Page 22505]]

Bethesda, MD 20892-5452, (301) 594-8894, begumn@niddk.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)


    Dated: May 9, 2018.
David D. Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-10237 Filed 5-14-18; 8:45 am]
 BILLING CODE 4140-01-P

22504 Federal Register / Vol. 83, No. 94 / Tuesday, May 15, 2018 / Notices

Name of Committee: Vascular and DEPARTMENT OF HEALTH AND property such as patentable material,
Hematology Integrated Review Group; HUMAN SERVICES and personal information concerning
Vascular Cell and Molecular Biology Study individuals associated with the grant
Section. National Institutes of Health applications, the disclosure of which
Date: June 11–12, 2018. would constitute a clearly unwarranted
Time: 8:30 a.m. to 5:00 p.m. National Institute of Biomedical invasion of personal privacy.
Agenda: To review and evaluate grant Imaging and Bioengineering; Notice of
Closed Meeting Name of Committee: National Institute of
applications.
Diabetes and Digestive and Kidney Diseases
Place: The William F. Bolger Center, 9600 Special Emphasis Panel; DDK–B Conflicts.
Pursuant to section 10(d) of the
Newbridge Drive, Potomac, MD 20854. Date: June 6–7, 2018.
Federal Advisory Committee Act, as
Contact Person: Larry Pinkus, Ph.D., Time: 8:00 a.m. to 12:00 p.m.
amended, notice is hereby given of the
Scientific Review Officer, Center for Agenda: To review and evaluate grant
meeting of the National Institute of
Scientific Review, National Institutes of applications.
Biomedical Imaging and Bioengineering Place: Hilton Garden Inn Bethesda, 7301
Health, 6701 Rockledge Drive, Room 4132,
MSC 7802, Bethesda, MD 20892, (301) 435–
Special Emphasis Panel. Waverly Street, Bethesda, MD 20814.
The meeting will be closed to the Contact Person: Thomas A. Tatham, Ph.D.,
1214, pinkusl@csr.nih.gov.
public in accordance with the Scientific Review Officer, Review Branch,
Name of Committee: Center for Scientific provisions set forth in sections DEA, NIDDK, National Institutes of Health,
Review Special Emphasis Panel; PARs18–596 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Room 7021, 6707 Democracy Boulevard,
and 18–661: Research on Current Topics in as amended. The grant applications and Bethesda, MD 20892–5452, (301) 594–3993,
Alzheimer’s Disease and Its Related the discussions could disclose tathamt@mail.nih.gov.
Dementias. confidential trade secrets or commercial Name of Committee: National Institute of
Date: June 11, 2018. Diabetes and Digestive and Kidney Diseases
property such as patentable material,
Time: 11:00 a.m. to 4:00 p.m. Special Emphasis Panel; NIDDK Clinical
and personal information concerning
Agenda: To review and evaluate grant Trials.
individuals associated with the grant
applications. Date: June 19, 2018.
applications, the disclosure of which Time: 1:30 p.m. to 3:30 p.m.
Place: National Institutes of Health, 6701
would constitute a clearly unwarranted Agenda: To review and evaluate grant
Rockledge Drive, Bethesda, MD 20892
invasion of personal privacy. applications.
(Telephone Conference Call).
Contact Person: Cristina Backman, Ph.D., Name of Committee: National Institute of Place: National Institutes of Health, Two
Biomedical Imaging and Bioengineering Democracy Plaza, 6707 Democracy
Scientific Review Officer, ETTN IRG, Center
Special Emphasis Panel; K Award—R13 Boulevard, Bethesda, MD 20892 (Telephone
for Scientific Review, National Institutes of Conference Call).
Review Meeting (2018/10)
Health, 6701 Rockledge Drive, Room 5211, Contact Person: Elena Sanovich, Ph.D.,
Date: June 25, 2018.
MSC 7846, Bethesda, MD 20892, 301–480– Time: 10:00 a.m. to 6:00 p.m. Scientific Review Officer, Review Branch,
9069, cbackman@mail.nih.gov. Agenda: To review and evaluate grant DEA, NIDDK, National Institutes of Health,
Name of Committee: Center for Scientific applications. Room 7351, 6707 Democracy Boulevard,
Review Special Emphasis Panel; PAR–18– Place: National Institutes of Health, Two Bethesda, MD 20892–2542, 301–594–8886,
105: Ancillary Studies to Identify Behavioral Democracy Plaza, Suite 920, 6707 Democracy sanoviche@mail.nih.gov.
and/or Psychological Phenotypes Plaza, Bethesda, MD 20892 (Virtual Meeting). Name of Committee: National Institute of
Contributing to Obesity. Contact Person: John K. Hayes, Ph.D., Diabetes and Digestive and Kidney Diseases
Scientific Review Officer, 6707 Democracy Special Emphasis Panel; NIDDK Program
Date: June 11, 2018.
Boulevard, Suite 959, Democracy Two, Projects.
Time: 2:00 p.m. to 3:30 p.m. Bethesda, MD 20892, (301) 451–3398, Date: June 21, 2018.
Agenda: To review and evaluate grant hayesj@mail.nih.gov. Time: 11:30 a.m. to 3:00 p.m.
applications. Agenda: To review and evaluate grant
Dated: May 9, 2018.
Place: Mayflower Park Hotel, 405 Olive applications.
Way, Seattle, WA 98101. David D. Clary,
Place: National Institutes of Health, Two
Contact Person: Stacey FitzSimmons, Program Analyst, Office of Federal Advisory Democracy Plaza, 6707 Democracy
Ph.D., Scientific Review Officer, Center for Committee Policy. Boulevard, Bethesda, MD 20892 (Telephone
Scientific Review, National Institutes of [FR Doc. 2018–10236 Filed 5–14–18; 8:45 am] Conference Call).
Health, 6701 Rockledge Drive, Room 3114, BILLING CODE 4140–01–P Contact Person: Elena Sanovich, Ph.D.,
MSC 7808, Bethesda, MD 20892, 301–451– Scientific Review Officer, Review Branch,
9956, fitzsimmonss@csr.nih.gov. DEA, IDDK, National Institutes of Health,
DEPARTMENT OF HEALTH AND Room 7351, 6707 Democracy Boulevard,
(Catalogue of Federal Domestic Assistance Bethesda, MD 20892–2542, 301–594–8886,
Program Nos. 93.306, Comparative Medicine; HUMAN SERVICES
sanoviche@mail.nih.gov.
93.333, Clinical Research, 93.306, 93.333, Name of Committee: National Institute of
National Institutes of Health
93.337, 93.393–93.396, 93.837–93.844, Diabetes and Digestive and Kidney Diseases
93.846–93.878, 93.892, 93.893, National National Institute of Diabetes and Special Emphasis Panel; PAR–18–108:
Institutes of Health, HHS) Digestive and Kidney Diseases; Notice NIDDK Exploratory Clinical Trials for Small
Dated: May 10, 2018. of Closed Meetings Business (R44 Clinical Trial Required).
Date: June 21, 2018.
Natasha M. Copeland, Pursuant to section 10(d) of the Time: 12:00 p.m. to 4:00 p.m.
Program Analyst, Office of Federal Advisory Federal Advisory Committee Act, as Agenda: To review and evaluate grant
Committee Policy. amended, notice is hereby given of the applications.
daltland on DSKBBV9HB2PROD with NOTICES

[FR Doc. 2018–10314 Filed 5–14–18; 8:45 am] following meetings.The meetings will be Place: National Institutes of Health, Two
closed to the public in accordance with Democracy Plaza, 6707 Democracy
BILLING CODE 4140–01–P
Boulevard, Bethesda, MD 20892 (Telephone
the provisions set forth in sections Conference Call).
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Contact Person: Najma S. Begum, Ph.D.,
as amended. The grant applications and Scientific Review Officer, Review Branch,
the discussions could disclose DEA, NIDDK, National Institutes of Health,
confidential trade secrets or commercial Room 7349, 6707 Democracy Boulevard,

VerDate Sep<11>2014 20:27 May 14, 2018 Jkt 244001 PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 E:\FR\FM\15MYN1.SGM 15MYN1

Federal Register / Vol. 83, No. 94 / Tuesday, May 15, 2018 / Notices 22505

Bethesda, MD 20892–5452, (301) 594–8894, Contact Person: Melinda Nelson, Acting Agenda: To review and evaluate personal
begumn@niddk.nih.gov. Director, National Institute of Arthritis and qualifications and performance, and
(Catalogue of Federal Domestic Assistance Musculoskeletal and Skin Diseases Grants competence of individual investigators.
Program Nos. 93.847, Diabetes, Management Branch, 45 Center Drive, Place: NIH Rocky Mountain Laboratories
Endocrinology and Metabolic Research; Natcher Building, Room 5A49, Bethesda, MD Building A, Seminar Room, 903 S 4th Street,
93.848, Digestive Diseases and Nutrition 20892, (301) 435–5278, nelsonm@ Hamilton, MT 59840.
Research; 93.849, Kidney Diseases, Urology exchange.nih.gov. Contact Person: Steven M. Holland, MD,
and Hematology Research, National Institutes Any interested person may file written Ph.D., Chief, Laboratory of Clinical Infectious
of Health, HHS) comments with the committee by forwarding Diseases, National Institutes of Health/
the statement to the Contact Person listed on NIAID, Hatfield Clinical Research Center,
Dated: May 9, 2018. this notice. The statement should include the Bethesda, MD 20892–1684, 301–402–7684,
David D. Clary, name, address, telephone number and when sholland@mail.nih.gov.
applicable, the business or professional In the interest of security, NIH has
Program Analyst, Office of Federal Advisory instituted stringent procedures for entrance
Committee Policy. affiliation of the interested person.
In the interest of security, NIH has onto the NIH campus. All visitor vehicles,
[FR Doc. 2018–10237 Filed 5–14–18; 8:45 am] including taxicabs, hotel, and airport shuttles
instituted stringent procedures for entrance
BILLING CODE 4140–01–P
onto the NIH campus. All visitor vehicles, will be inspected before being allowed on
campus. Visitors will be asked to show one
including taxicabs, hotel, and airport shuttles
form of identification (for example, a
will be inspected before being allowed on
DEPARTMENT OF HEALTH AND government-issued photo ID, driver’s license,
campus. Visitors will be asked to show one
HUMAN SERVICES or passport) and to state the purpose of their
form of identification (for example, a
visit.
government-issued photo ID, driver’s license,
National Institutes of Health or passport) and to state the purpose of their (Catalogue of Federal Domestic Assistance
visit. Program Nos. 93.855, Allergy, Immunology,
National Institute of Arthritis and (Catalogue of Federal Domestic Assistance
and Transplantation Research; 93.856,
Musculoskeletal and Skin Diseases; Microbiology and Infectious Diseases
Program Nos. 93.846, Arthritis,
Notice of Meeting Research, National Institutes of Health, HHS)
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS) Dated: May 10, 2018.
Pursuant to section 10(d) of the
Dated: May 10, 2018. Natasha M. Copeland,
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is Sylvia L. Neal, Program Analyst, Office of Federal Advisory
Committee Policy.
hereby given of a meeting of the Program Analyst, Office of Federal Advisory
[FR Doc. 2018–10317 Filed 5–14–18; 8:45 am]
National Arthritis and Musculoskeletal Committee Policy.
and Skin Diseases Advisory Council. BILLING CODE 4140–01–P
[FR Doc. 2018–10318 Filed 5–14–18; 8:45 am]
The meeting will be open to the BILLING CODE 4140–01–P
public as indicated below, with
attendance limited to space available. DEPARTMENT OF HEALTH AND
Individuals who plan to attend and HUMAN SERVICES
DEPARTMENT OF HEALTH AND
need special assistance, such as sign HUMAN SERVICES National Institutes of Health
language interpretation or other
reasonable accommodations, should National Institutes of Health Center For Scientific Review; Notice of
notify the Contact Person listed below Closed Meetings
in advance of the meeting. National Institute of Allergy and
The meeting will be closed to the Infectious Diseases; Notice of Closed Pursuant to section 10(d) of the
public in accordance with the Meeting Federal Advisory Committee Act, as
provisions set forth in sections amended (5 U.S.C. App.), notice is
Pursuant to section 10(d) of the hereby given of the following meetings.
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Federal Advisory Committee Act, as The meetings will be closed to the
as amended. The grant applications and
amended, notice is hereby given of a public in accordance with the
the discussions could disclose
meeting of the Division of Intramural provisions set forth in sections
confidential trade secrets or commercial
Research Board of Scientific Counselors. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
property such as patentable material,
and personal information concerning The meeting will be closed to the as amended. The grant applications and
individuals associated with the grant public in accordance with the the discussions could disclose
applications, the disclosure of which provisions set forth in section confidential trade secrets or commercial
would constitute a clearly unwarranted 552b(c)(6), Title 5 U.S.C., as amended property such as patentable material,
invasion of personal privacy. for the review, discussion, and and personal information concerning
evaluation of individual intramural individuals associated with the grant
Name of Committee: National Arthritis and applications, the disclosure of which
Musculoskeletal and Skin Diseases Advisory programs and projects conducted by the
NATIONAL INSTITUTE OF ALLERGY would constitute a clearly unwarranted
Council.
Date: June 12, 2018. AND INFECTIOUS DISEASES, invasion of personal privacy.
Open: 8:30 a.m. to 12:00 p.m. including consideration of personnel Name of Committee: Healthcare Delivery
Agenda: To discuss program policies and qualifications and performance, and the and Methodologies Integrated Review Group;
issues. competence of individual investigators, Dissemination and Implementation Research
Place: National Institutes of Health, the disclosure of which would in Health Study Section.
daltland on DSKBBV9HB2PROD with NOTICES

Building 31, Conference Room 6C6, 31 constitute a clearly unwarranted Date: June 13–14, 2018.
Center Drive, Bethesda, MD 20892. Time: 8:00 a.m. to 6:00 p.m.
invasion of personal privacy.
Closed: 1:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant
Agenda: To review and evaluate grant Name of Committee: Division of Intramural applications.
applications. Research, Board of Scientific Counselors, Place: Sir Francis Drake Hotel, 450 Powell
Place: National Institutes of Health, NIAID. Street at Sutter, San Francisco, CA 94102.
Building 31, Conference Room 6C6, 31 Date: June 11–13, 2018. Contact Person: Yvonne Owens Ferguson,
Center Drive, Bethesda, MD 20892. Time: 8:00 a.m. to 10:00 a.m. Ph.D., Scientific Review Officer, Center for

VerDate Sep<11>2014 20:27 May 14, 2018 Jkt 244001 PO 00000 Frm 00065 Fmt 4703 Sfmt 4703 E:\FR\FM\15MYN1.SGM 15MYN1

Document Created: 2018-05-15 00:33:55
Document Modified: 2018-05-15 00:33:55

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		June 6-7, 2018.
FR Citation		83 FR 22504

83 FR 22504 - National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 83, Issue 94 (May 15, 2018)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health